205 related articles for article (PubMed ID: 22471341)
1. Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study.
Miro JM; Montejo M; Castells L; Rafecas A; Moreno S; Agüero F; Abradelo M; Miralles P; Torre-Cisneros J; Pedreira JD; Cordero E; de la Rosa G; Moyano B; Moreno A; Perez I; Rimola A;
Am J Transplant; 2012 Jul; 12(7):1866-76. PubMed ID: 22471341
[TBL] [Abstract][Full Text] [Related]
2. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
3. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
[TBL] [Abstract][Full Text] [Related]
4. Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.
Sawinski D; Goldberg DS; Blumberg E; Abt PL; Bloom RD; Forde KA
Clin Infect Dis; 2015 Oct; 61(7):1054-62. PubMed ID: 26082506
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous clearance of HCV in HIV-hepatitis C virus coinfected liver transplant patients: prospective study.
Gutiérrez-Moreno M; Bernal-Bellido C; Suárez-Artacho G; Alamo-Martínez JM; Marín-Gómez LM; Serrano-Díaz-Canedo J; Padillo-Ruiz FJ; Gómez-Bravo MA
Transplant Proc; 2012 Sep; 44(7):2100-2. PubMed ID: 22974923
[TBL] [Abstract][Full Text] [Related]
6. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.
Duclos-Vallée JC; Féray C; Sebagh M; Teicher E; Roque-Afonso AM; Roche B; Azoulay D; Adam R; Bismuth H; Castaing D; Vittecoq D; Samuel D;
Hepatology; 2008 Feb; 47(2):407-17. PubMed ID: 18098295
[TBL] [Abstract][Full Text] [Related]
7. Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.
Castells L; Rimola A; Manzardo C; Valdivieso A; Montero JL; Barcena R; Abradelo M; Xiol X; Aguilera V; Salcedo M; Rodriguez M; Bernal C; Suarez F; Antela A; Olivares S; Del Campo S; Laguno M; Fernandez JR; de la Rosa G; Agüero F; Perez I; González-García J; Esteban-Mur JI; Miro JM;
J Hepatol; 2015 Jan; 62(1):92-100. PubMed ID: 25127748
[TBL] [Abstract][Full Text] [Related]
8. Outcome and management of HCV/HIV coinfection pre- and post-liver transplantation. A 2015 update.
Miro JM; Stock P; Teicher E; Duclos-Vallée JC; Terrault N; Rimola A
J Hepatol; 2015 Mar; 62(3):701-11. PubMed ID: 25450714
[TBL] [Abstract][Full Text] [Related]
9. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study.
Manzardo C; Londoño MC; Castells L; Testillano M; Luis Montero J; Peñafiel J; Subirana M; Moreno A; Aguilera V; Luisa González-Diéguez M; Calvo-Pulido J; Xiol X; Salcedo M; Cuervas-Mons V; Manuel Sousa J; Suarez F; Serrano T; Ignacio Herrero J; Jiménez M; Fernandez JR; Giménez C; Del Campo S; Esteban-Mur JI; Crespo G; Moreno A; de la Rosa G; Rimola A; Miro JM;
Am J Transplant; 2018 Oct; 18(10):2513-2522. PubMed ID: 29963780
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
Terrault NA; Roland ME; Schiano T; Dove L; Wong MT; Poordad F; Ragni MV; Barin B; Simon D; Olthoff KM; Johnson L; Stosor V; Jayaweera D; Fung J; Sherman KE; Subramanian A; Millis JM; Slakey D; Berg CL; Carlson L; Ferrell L; Stablein DM; Odim J; Fox L; Stock PG;
Liver Transpl; 2012 Jun; 18(6):716-26. PubMed ID: 22328294
[TBL] [Abstract][Full Text] [Related]
11. A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients.
Locke JE; Mehta S; Reed RD; MacLennan P; Massie A; Nellore A; Durand C; Segev DL
J Am Soc Nephrol; 2015 Sep; 26(9):2222-9. PubMed ID: 25791727
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study.
Moreno A; Cervera C; Fortún J; Blanes M; Montejo E; Abradelo M; Len O; Rafecas A; Martín-Davila P; Torre-Cisneros J; Salcedo M; Cordero E; Lozano R; Pérez I; Rimola A; Miró JM;
Liver Transpl; 2012 Jan; 18(1):70-81. PubMed ID: 21898772
[TBL] [Abstract][Full Text] [Related]
13. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.
de Vera ME; Dvorchik I; Tom K; Eghtesad B; Thai N; Shakil O; Marcos A; Demetris A; Jain A; Fung JJ; Ragni MV
Am J Transplant; 2006 Dec; 6(12):2983-93. PubMed ID: 17062005
[TBL] [Abstract][Full Text] [Related]
14. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
[TBL] [Abstract][Full Text] [Related]
15. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
[TBL] [Abstract][Full Text] [Related]
16. Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients.
Terrault N; Reddy KR; Poordad F; Curry M; Schiano T; Johl J; Shaikh O; Dove L; Shetty K; Millis M; Schiff E; Regenstein F; Barnes D; Barin B; Peters M; Roland M; Stock P;
Am J Transplant; 2014 May; 14(5):1129-35. PubMed ID: 24636466
[TBL] [Abstract][Full Text] [Related]
17. IL28B polymorphism, pretreatment CXCL10, and HCV RNA levels predict treatment response in racially diverse HIV/HCV coinfected and HCV monoinfected patients.
Zeremski M; Dimova RB; Makeyeva J; Sipley JD; Jacobson IM; Rennert H; Talal AH
J Acquir Immune Defic Syndr; 2013 May; 63(1):9-16. PubMed ID: 23274935
[TBL] [Abstract][Full Text] [Related]
18. Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort.
Quaranta MG; Ferrigno L; Tata X; D'Angelo F; Coppola C; Ciancio A; Bruno SR; Loi M; Giorgini A; Margotti M; Cossiga V; Brancaccio G; Dallio M; De Siena M; Cannizzaro M; Cavalletto L; Massari M; Mazzitelli M; De Leo P; Laccabue D; Baiocchi L; Kondili LA
BMC Infect Dis; 2021 May; 21(1):413. PubMed ID: 33947337
[TBL] [Abstract][Full Text] [Related]
19. [Liver transplantation for patients infected with both HIV and HCV or HIV and HBV].
Duclos-Vallée JC; Teicher E; Vittecoq D; Samuel D
Med Sci (Paris); 2007; 23(8-9):723-8. PubMed ID: 17875290
[TBL] [Abstract][Full Text] [Related]
20. Sustained virological response according to the type of early virological response in HCV and HCV/HIV.
Lerias de Almeida PR; Alves de Mattos A; Valle Tovo C
Ann Hepatol; 2010; 9(2):150-5. PubMed ID: 20526007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
